NIH wants every participant in the clinical research it funds to hear what the study found. In NOT-OD-26-113, released August 27, 2026, NIH proposed a new policy on NIH results sharing: researchers and institutions would have to share summary level study results with clinical research participants in plain language, unless doing so is justifiably not appropriate. The comment period closed on October 26, 2026, so the next step is a final policy.
For IRB offices, human research protection programs, and clinical research offices, this is more than a communications task. It touches protocol design, consent language, exception requests, study closeout, and progress reporting. Offices that plan now will avoid a scramble once a final policy and effective date are set.
This post summarizes what NIH proposed, the deadlines in the draft, and practical steps IRB offices can take to get ready.
In This Article
- What NIH Proposed in NOT-OD-26-113
- Key NIH Results Sharing Requirements and Deadlines
- What NIH Results Sharing Means for IRB Offices
- How IRB Offices Can Prepare for NIH Results Sharing Now
- How Fibi Helps with IRB / Human Subjects Oversight
- Key Takeaways
What NIH Proposed in NOT-OD-26-113
NIH published the draft as a request for information titled Draft NIH Policy on Sharing Summary Level Study Results with Clinical Research Participants. NIH notes that existing policies, such as the Data Management and Sharing Policy, ClinicalTrials.gov reporting, and the Public Access Policy, have focused on sharing with the scientific community rather than directly with participants. The new policy is meant to close that gap, and NIH says it supports the goals of HHS’s Operation TrialBlazer.
Who and what is covered
As drafted, the policy applies to all clinical research, including clinical trials, supported in whole or in part by NIH, regardless of funding level or mechanism. That includes grants, cooperative agreements, contracts, Other Transactions, and the NIH Intramural Research Program. Studies under Exemption 4 of the Common Rule (45 CFR 46.104(d)(4)) are not considered clinical research under the policy’s definition.
What summary level results are
NIH defines summary level study results as a concise overview of a study after all data are compiled and analyzed. They cover the objective, conduct, methodology as appropriate, aggregate outcomes or key findings, relevance, limitations, and potential implications. They are distinct from individual research results, such as a participant’s own lab values.
When it would start
The draft would apply to competing applications, competitive revisions, and new contract proposals received on or after a date six months after a final policy is published. Compliance would be written into award terms and conditions, and noncompliance could lead to enforcement actions, including special terms or termination.
Key NIH Results Sharing Requirements and Deadlines
The draft sets different timelines depending on the type of study:
| Study type | When results must be shared |
|---|---|
| Clinical trials | No later than one year after the primary completion date, or by the ClinicalTrials.gov results reporting date, whichever is later |
| Extramural clinical research that is not a trial | No later than the end of the period of performance, if analyses are complete; otherwise a status update to NIH and participants |
| NIH intramural clinical research | Annual status updates to participants, starting no later than six months after the effective date |
The draft also includes these requirements:
- Offer to all participants: results must be offered to participants, whether or not they choose to receive them.
- Exceptions: if sharing is justifiably not appropriate, researchers may request an exception, subject to approval by the NIH Institute, Center, or Office. Generally, the justification should be submitted before the first participant enrolls.
- Changes in circumstances: if sharing becomes impossible, participants must be told why. Any change is subject to NIH approval and, as necessary, IRB approval.
- Confirmation: extramural institutions would confirm in the Research Performance Progress Report (RPPR) at closeout that results or a status update were shared.
- Plain language: communication must be clear and concise, without unnecessary jargon, acronyms, or expressions.
What NIH Results Sharing Means for IRB Offices
The draft encourages researchers to consult with participants, IRBs, and institutional officials to build results sharing into study design and planning. In practice, that puts IRB offices in the middle of the process at several points:
- Initial review: protocols will need a results sharing plan, or a documented exception request, before enrollment begins.
- Consent: consent forms should tell participants that results will be offered, how and when, and how they can opt out of receiving them.
- Participant materials: plain-language summaries are participant-facing communications, so many institutions may treat them as materials needing IRB review.
- Amendments: changes to sharing plans may require IRB approval, adding to amendment volume.
- Closeout: study closure workflows will need to confirm that results or status updates were delivered, so the institution can report it in the RPPR.
This arrives alongside the upcoming Common Rule changes, so many offices will be updating SOPs and templates at the same time. Coordinating both efforts can save effort.
How IRB Offices Can Prepare for NIH Results Sharing Now
1. Inventory NIH-funded clinical research
Identify which active and upcoming protocols are NIH-supported clinical research, and flag clinical trials separately because of their ClinicalTrials.gov-linked deadline. Note studies that may qualify for Exemption 4, which falls outside the policy.
2. Add an NIH results sharing section to protocol templates
Ask investigators to describe what will be shared, in what format, through which channel, and on what timeline. Include a field for a planned exception and its justification.
3. Update consent templates
Draft standard consent language explaining that participants will be offered summary level results, how they will receive them, and how to update contact preferences. Consider permissions for sharing with parents, guardians, or caregivers where appropriate.
4. Define an exception review pathway
Because justifications are generally due before the first enrollment, decide who reviews exception rationales internally before they go to NIH, and how the IRB will document the outcome.
5. Build plain-language support
Plain-language summaries take skill. Consider shared templates, a health literacy reviewer, or community advisory input, and decide whether summaries need IRB review before release.
6. Connect closeout to RPPR reporting
Add a step to study closure that records whether results or a status update were shared and when. Share that record with sponsored programs so the final RPPR is accurate.
7. Plan for costs
NIH acknowledges that results sharing will incur costs and asked for input on reasonable and necessary costs. Work with investigators and budget staff to include these activities in proposal budgets. As with the NIH burden-reduction RFI, watch for NIH guidance that aims to keep administrative burden low.
How Fibi Helps with IRB / Human Subjects Oversight
Results sharing touches the full life of a protocol, from submission to closure. The IRB / Human Subjects module in Fibi IRB management software helps offices manage it in one place:
- Configurable protocol forms: add results sharing plan and exception questions to submission forms, with required fields so nothing is missed.
- Consent document management: keep approved consent templates and versions together, so updated results sharing language is easy to roll out.
- Amendment and review workflows: route changes to sharing plans, and participant-facing summaries, through the right reviewers with a full audit trail.
- Closeout tracking: record when results or status updates were shared and flag studies that are approaching their deadlines.
- Integration with awards: link protocols to NIH awards in Fibi so sponsored programs can confirm results sharing in the RPPR.
Key Takeaways
- New requirement coming: NIH proposed in NOT-OD-26-113 that summary level results from all NIH-supported clinical research be shared with participants in plain language.
- Broad scope: the draft covers trials and other clinical research across every NIH funding mechanism, including intramural research.
- Clear deadlines: trials would share within one year of primary completion or by the ClinicalTrials.gov deadline, whichever is later; other research by the end of the period of performance.
- Exceptions need early planning: justifications should generally be submitted before the first participant enrolls.
- Start now: IRB offices can update protocol and consent templates, define an exception pathway, and link closeout to RPPR reporting before a final policy arrives.